U.S. Electrical Stock News

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Editas Medicine, Inc. ( NASDAQ:EDIT ) shares have retraced a considerable 29% in the last month, reversing a fair...

Key Insights JBS' significant private companies ownership suggests that the key decisions are influenced by...

If you have ever wondered whether Vertex stock is trading at a bargain or an inflated price, you are in the right place for some answers. After a rough few months, Vertex shares have dropped by 20.7% over the last week and are down 54.4% over the past year, suggesting a dramatic shift in market sentiment around the company. Much of this decline has been set against a backdrop of challenging headlines, including industry-wide volatility in the software sector, as well as broader market...

Premier (PINC) reported a net profit margin of just 0.7% this quarter, a sharp drop from last year’s 11.2%, with earnings having declined at an average annual rate of -25.5% over the past five years. Despite recent pressures, the company is now profitable and is forecasting a robust 32.6% annual earnings growth over the next three years, which is double the 16% expected for the US market overall. These mixed results, combined with a one-off $162.9 million loss, have pushed Premier’s shares to...

On November 3, 2025, Prelude Therapeutics announced a private placement, raising US$25,000,000 by issuing 6,250,000 shares at US$4 each, with participation from Incyte Corporation. Institutional interest from a company like Incyte can be viewed as an endorsement of Prelude’s research direction and funding outlook. We’ll explore how Incyte’s involvement in the private placement shapes Prelude’s investment narrative and financial flexibility. The best AI stocks today may lie beyond giants like...

Wondering if StepStone Group is a hidden gem or getting pricey? You are not alone, and we're here to break down the numbers in plain English. The stock has seen returns of 5.4% year-to-date and 5.9% over the last year, despite minor pullbacks in the last week and month. StepStone's share price has been influenced by recent headlines detailing its continued expansion in private markets and new fund launches, which have caught the eye of both industry watchers and investors. This activity has...

Better Home & Finance (BETR) is in the spotlight after activist investor Eric Jackson endorsed the company for its ability to transform the mortgage sector using AI and digital technologies. Jackson drew comparisons to top e-commerce innovators. See our latest analysis for Better Home & Finance Holding. Shares of Better Home & Finance have been on a tear, climbing a remarkable 609.96% year-to-date in terms of share price return, with explosive momentum particularly in the last quarter. While...

Sequans Communications (SQNS) is currently unprofitable, but has managed to reduce losses by 42.6% per year over the past five years. Revenue is expected to grow 25.61% annually, well ahead of the US market average growth rate of 10.5%. However, the company is still forecast to remain in the red over the next three years. Investors looking at the setup will see attractive top-line growth prospects and a price-to-sales ratio of 2.7x, which is notably lower than the semiconductor industry...

Caribou Biosciences (CRBU) is attracting fresh attention after releasing positive interim data from phase 1 trials of its lead CAR-T therapies, vispacabtagene regedleucel and CB-011, for lymphoma and multiple myeloma. See our latest analysis for Caribou Biosciences. Momentum has picked up for Caribou Biosciences following its positive clinical trial updates and upcoming pivotal studies, but recent volatility is hard to ignore. The stock’s 1-day share price return dropped 10.7% after the data...

Denny's (DENN) net profit margin slipped to 2.2% from last year's 3.9%, with annual earnings declining by 11.9% over the past five years and recent negative growth that makes year-on-year comparisons tough. Investors may be watching closely as revenue is only expected to grow at 3.4% per year, lagging well behind the broader US market’s projected 10.5%. However, despite these lackluster trends and a relatively rich valuation, forecasts are calling for a sharp rebound in earnings, with a...

Heidrick & Struggles International (HSII) reported net profit margins of 3.1% this period, down from 3.6% previously. A significant one-off loss of $39.4 million weighed on earnings over the last twelve months. Over the past five years, the company managed to grow earnings by 11.2% per year, although the most recent year saw negative earnings growth. Looking ahead, forecasts suggest a strong rebound with expected annual earnings growth of 28.4% and this rate exceeds the US market even as...

Air Lease (AL) reported a major jump in profitability, posting net profit margins of 33.2% compared to 17.9% last year, and nearly doubling earnings growth to 97.2% year over year, powered by a one-off $727.2 million gain. Despite the boost, consensus now points to a 20.6% annual decline in earnings for the next three years, with revenue expected to grow at 7.3% yearly, which trails the broader US market’s 10.5% pace. Margins are considerably improved, but investors face a complex picture...

Wondering if ICF International is an overlooked bargain or a value trap? If you're curious about what the numbers say, you're in the right place. ICF International's shares have pulled back sharply, losing 8.5% over the past week and 14.3% in the past month. They are now down 31.6% year-to-date. Recently, ICF International announced the acquisition of a leading energy and utilities consulting firm. This sparked new conversations around its long-term strategy. Some investors see this move as...

PLAYSTUDIOS (MYPS) saw its losses accelerate at an average rate of 56.9% per year over the last five years, and the company remains unprofitable, with forecasts calling for continued losses through the next three years. Revenue is also projected to decline by 2.1% annually, adding further pressure on profit margins. Despite these tough numbers, MYPS trades at $0.82, a notable discount to its estimated fair value of $3.40. Valuation metrics stand out versus peers in the sector. See our full...

Energys Group (ENGS) has reported continued losses, with net losses growing at an average annual rate of 14.1% over the past five years. The company's Price-to-Sales Ratio stands at 17.5x, which is significantly above the industry average of 1.4x and the peer group’s 4.8x. With no concrete signs of margin improvement or profit growth in the recent data, investors currently face a situation defined by persistently elevated valuation multiples and a lack of positive earnings momentum. See our...

Exagen (XGN) is set to outpace the broader US market with revenue forecast to rise 11.7% per year, compared to the expected 10.5% market growth. Despite a persistent lack of profitability, the company has trimmed losses at an average annual rate of 4.7% over the past five years. The narrative is defined by rapid top-line expansion and shares trading at a 3.7x Price-to-Sales Ratio, which is below both the peer average of 6.5x and the sector’s 10.8x benchmark. The current share price of $10.77...

Wondering if Barrett Business Services could be a hidden value play or just another stock on your watchlist? Let’s dig into what really matters when sizing up its worth. After climbing a solid 8.4% over the past year and delivering an impressive 139.1% return in the last five years, the stock has recently cooled off, sliding 2.7% in the past week and 10.4% this past month. Shares have drifted in recent weeks as sector momentum faded and investors weighed mixed signals from broader labor...

Gaia (GAIA) remains in the red, recording unprofitable results with net losses worsening at an average annual rate of 48.7% over the past five years. Despite the ongoing losses, forecasts now point to rapid improvement, with earnings expected to grow by 95.93% per year and a return to profitability within three years. This would outpace most of the market. Meanwhile, revenue growth is set to reach 14.1% annually, which exceeds the predicted 10.5% average across the US market. At a trading...

Integral Ad Science Holding (IAS) posted current net profit margins of 7.9%, improving from 6.4% a year ago, while earnings grew 42.9% over the last twelve months. This is an impressive figure, though it remains below the robust five-year average growth rate of 73.5% per year. Looking ahead, analysts project revenue to rise at 10.1% per year and forecast significant earnings growth at 23.1% per year, both pointing to momentum outpacing much of the US market. With margins expanding and growth...

Anywhere Real Estate (HOUS) is currently unprofitable, with losses over the past five years growing at an annual rate of 18.2%. Shares are trading at $10.98, below the estimated fair value of $16.31 based on discounted cash flow analysis. Earnings are forecast to rebound sharply, with 128.7% annual EPS growth expected, and the company is projected to return to profitability within three years. However, revenue is only forecast to rise by 8.4% per year, which trails the broader US market’s...

Emergent BioSolutions recently reported third-quarter 2025 results, with revenue of US$231.1 million and net income of US$51.2 million, and raised its full-year 2025 guidance for both revenue and net income. The company's stronger-than-expected performance was supported by growth in NARCAN nasal spray, new U.S. government and international contracts, and a completed share repurchase program. We'll now examine how the company's upgraded full-year outlook and growth in core product lines may...

PotlatchDeltic (PCH) delivered a sharp turnaround in profitability this quarter, with its net profit margin climbing to 5.8%, up from just 1.6% a year ago, and earnings rising 288.4% year-over-year. This is far stronger than its five-year average, which saw earnings declining 38.9% per year. Looking ahead, the company is forecasting annual earnings growth of 17.9%, set to outpace the broader US market, while management values shares below their estimated fair value at $38.95. These improving...

Ever wondered if Alight could be a hidden gem or is already priced to perfection? If you’re on the hunt for value, you might be surprised by what the numbers reveal. It's been a rollercoaster for Alight’s shareholders. They have seen the stock drop 12.3% in the last week and a staggering 60.0% since the start of the year, signaling a big shift in how the market values the business. Recently, Alight made headlines by entering new partnerships that aim to strengthen its position in the...